Search

SEARCH FOR ANTAGONISTS OF NR3C4 RECEPTOR

Brylev M.I., Ramenskaya G.V., Lotorev D.S., Mukhacheva E.S., Kuznetsova N.B., Pavlova L.A., Lizunov A.U., Pelevin N.A.

Introduction. One of the main types of a hormonal therapy in the treatment of the cancer of the prostate gland is the antagonists of the NR3C4 (nuclear receptor subfamily 3, group C, member 4) receptor. It blocks binding of man’s hormones with receptors site, …